Ledger.Open graph →
SEC Form D · filed January 6, 2017

GALECTIN THERAPEUTICS INC

Offering
$10.0M
Sold
$3.0M
Exemption
Rule 506(b)
Industry
Pharmaceuticals
Location
NORCROSS, GA
Type

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (30)

Peter G. Traber · Norcross, GAExec · DirectorMarc G. Rubin · Norcross, GADirectorJames C. Czirr · Norcross, GADirectorGilbert S. Omenn · Norcross, GADirectorJohn G. Mauldin · Norcross, GADirectorGilbert F. Amelio · Norcross, GADirectorArthur R. Greenberg · Norcross, GADirectorSteven G. Prelack · Norcross, GADirectorKevin D. Freeman · Norcross, GADirectorJack W. Callicutt · Norcross, GAExecHarold H. Shlevin · Norcross, GAExecRoisin W. Addlestone · Grand Cayman, Cayman IslandsDirectorPaul A. Zweng · VANCOUVER, British Columbia, CanadaDirectorGregory Mulholland · Redwood City, CADirectorScott Brady · Redwood City, CADirectorMark Cupta · Redwood City, CAExecMargo J. Georgiadis · EMERYVILLE, CAExec · DirectorTheodore H. Zuconni · Norcross, GADirectorCarole J. Piwnica · EMERYVILLE, CADirectorJohn F. Morgan, Jr · Hilton Head Island, SCExec · DirectorJohn F. Morgan, Sr · Hilton Head Island, SCDirectorThomas A. Burkhart · Reno, NVDirectorScott A. Heffernan · Vancouver, British Columbia, CanadaDirectorWayne A. Johnstone · Vancouver, British Columbia, CanadaExec · DirectorBrenda A. Nowak · Vancouver, British Columbia, CanadaDirectorFrederic G. Hewett · Vancouver, British Columbia, CanadaDirectorJames A. Dawson · Vancouver, British Columbia, CanadaDirectorCharles L. Baxter · Mountain View, CADirectorHarold H. Shlevin · Norcross, GAExecTheodore H. Zuconni · Norcross, GADirector

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗